# Granules India Limited – FDA Inspection, Feb 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/granules-india-limited/e944d7ad-7bc6-4e13-834e-8dd487037e68
Source feed: FDA_Inspections

> FDA inspection 1118644 of Granules India Limited, February 14, 2020. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118644
- Company Name: Granules India Limited
- Inspection Date: 2020-02-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1248503 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/granules-india-limited/fafbbf18-17ed-4ac4-bd8a-6d8705e8c706)
- [FDA Inspection 1197727 - 2023-01-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/5bcaa406-f3bf-4468-a9af-bdf092122cfa)
- FDA Inspection 1050607 - 2018-03-23
- FDA Inspection 992723 - 2016-10-14
- FDA Inspection 918291 - 2015-03-13

Company: https://www.keypedia.com/companies/granules-india-limited/e2f27ea6-6e3b-4432-a874-d34393d76014

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
